Evidence map›Paper›PMID 28947277›Full record

ReviewBiochemical pharmacology2018

A timeline of hydrogen sulfide (H

Csaba Szabo

Open access · greenAbstract readHistorical ArticleReview
In one paragraph

Review in Biochemical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 1 synthesis or guideline pooled it, 262 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Self-bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Hydrogen Sulfide in Adipose Tissue Biology.Handbook of experimental pharmacology · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Sodium hydrogen sulfide restores HInflammopharmacology · 2025
    Article
  15. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  16. Gasotransmitter signaling in the brain: New frontiers for therapeutics.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Csaba SzaboDepartment of Anesthesiology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA. Electronic address: szabocsaba@aol.com.
The University of Texas Medical Branch at Galveston · US

Funding

Role of Hydrogen Sulfide in Colorectal TumorsR01CA175803 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HELLMICH, MARK R, SZABO, CSABA · 2014 to 2018
$1.5M
Regulation of cellular bioenergetics by hydrogen sulfideR01GM107846 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SZABO, CSABA · 2014 to 2017
$1.2M
NCI NIH HHS R01 CA175803NIGMS NIH HHS R01 GM107846
6 · The paper itself

Abstract

The history of H

Indexed as

AnimalsEnvironmental PollutantsGasotransmittersHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHumansHydrogen SulfideSignal TransductionEnvironmental PollutantsGasotransmittersHydrogen Sulfide3-Mercaptopyruvate sulfurtransferaseCystathionine gamma lyaseCystathionine-β-synthaseGasotransmittersNitric oxide

Identifiers

PMID28947277
PMCPMC5862769
OpenAlexW2758089352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.